59

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has significantlyimpacted medical practices globally, particularly in the management of pregnant women. Due to physiological and immunological changes, pregnant women are at a higher risk of severe COVID-19 complications, which can negatively affect both the mother and fetus. This article aims to analyze studies on COVID-19's impact on pregnancy during different gestational stages and propose preventive measures tailored to each trimester. The review includes data from studies in various countries, covering risks such as miscarriage, preeclampsia, preterm birth, and placental blood flow impairment across trimesters. Social factors like access to healthcare, psychological impacts, and long-term health consequences for both mother and child are also discussed.The findings emphasize the importance of preventive protocols and the need for further research on pregnancy management during the COVID-19 pandemic to enhance maternal and fetal outcomes

  • Read count 59
  • Date of publication 31-12-2024
  • Main LanguageIngliz
  • Pages15-21
English

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has significantlyimpacted medical practices globally, particularly in the management of pregnant women. Due to physiological and immunological changes, pregnant women are at a higher risk of severe COVID-19 complications, which can negatively affect both the mother and fetus. This article aims to analyze studies on COVID-19's impact on pregnancy during different gestational stages and propose preventive measures tailored to each trimester. The review includes data from studies in various countries, covering risks such as miscarriage, preeclampsia, preterm birth, and placental blood flow impairment across trimesters. Social factors like access to healthcare, psychological impacts, and long-term health consequences for both mother and child are also discussed.The findings emphasize the importance of preventive protocols and the need for further research on pregnancy management during the COVID-19 pandemic to enhance maternal and fetal outcomes

№ Author name position Name of organisation
1 Rajapova G.F. ! Tashkent Medical Academy
2 Muminova Z.A. ! Tashkent Medical Academy
№ Name of reference
1 1.Breslin N., Baptiste C., Gyamfi-Bannerman C., Miller R., Martinez R., Bernstein K. et al. Coronavirus disease 2019 among symptomatic and asymptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. American Journal of Obstetrics & Gynecology MFM. 2020; 2(2): 100118. DOI: 10.1016/j.ajogmf.2020.100118.2.Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection innine pregnant women: a retrospective review of medical records. Lancet. 2020; 395(10226): 809-815. DOI: 10.1016/S0140-6736(20)30360-3.3.Di Mascio D., Khalil A., Saccone G., Rizzo G., Buca D., Liberati M. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM. 2020; 2(2): 100107. DOI: 10.1016/j.ajogmf.2020.100107.4.Kahlert C.R., Mazzali C., Dubruc E., Bianco A., Mascha E., Parker R., Hernandez A. et al. Pregnancy and COVID-19: outcomes from a German multicenter study. Archives of Gynecology and Obstetrics. 2020; 402: 96-106. DOI: 10.1007/s00404-020-05796-7.5.Kaltenbach T., Grimm C., Pilch J., Gregor M., Schikora D., Thaler C., et al. Telemedicine in managing pregnancy during COVID-19 pandemic: German perspectives. Journal of Telemedicine and Telecare. 2021; 27(6): 467-474. DOI: 10.1177/1357633X20942017.6.Mathad J.S., Gupta A. Pulmonary infections in pregnancy. Seminars in Respiratory and Critical Care Medicine. 2017; 38(2): 174-184. DOI: 10.1055/s-0037-1602375.7.Malik A., El Masry K.M., Ravi M., Sayed F. Middle East respiratory syndrome coronavirus during pregnancy. Emerging Infectious Diseases. 2016; 22(3): 515-517. DOI: 10.3201/eid2203.151049.8.Холова З.Б., Шукуров Ф.И. Разработка и оценка модели прогнозирования развития фетоплацентарной дисфункции у женщин с covid-19//Материалы международной научно-практической конференции.г. Иркутск, 14-15 ноября, 2024 г.С.204-205.9.Ministry of Health of the Republic of Uzbekistan. Guidelines for COVID-19 prevention among pregnant women. 2021. 10.Poon L.C., Yang H., Lee J.C.S., Copel J.A., Leung T.Y., Zhang Y. et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound in Obstetrics & Gynecology. 2020; 55(5): 700-708. DOI: 10.1002/uog.22013.11.Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection in pregnancy. Version 8, Published 17 April 2020. 12.Kholova Z.B., Shukurov F.I.,Anvarova. Sh.A.Cytokine status in pregnant women with fetoplacentary dysfunction associated with COVID-19//American Journal of Medicine and Medical Sciences 2024,12(6): 537-541.13.Westgren M., PetterssonK., Hagberg H., Acharya G. Severe maternal morbidity and mortality associated with COVID-19: The risk should not be down-played. Acta Obstet. Gynecol. Scand.2020; 99(7): 815-816. DOI: 10.1111/aogs.13900.
Waiting